What's your insurance limit on vascepa refills?

How many refills does my insurance typically cover for Vascepa?

Insurance coverage for Vascepa (icosapent ethyl) refills varies depending on the health insurance plan and provider. However, it is generally considered an expensive medication, with a typical retail price ranging from $150 to $250 per month.

[1] According to the Vascepa website, the manufacturer, Amarin, offers a patient assistance program that provides free medication to eligible patients who are experiencing financial hardship and have a valid prescription.

On average, most insurance plans cover a 30-day supply of Vascepa for a copay ranging from $50 to $100. However, the maximum number of refills covered by insurance can vary significantly.

Typically, insurance plans covering Vascepa have a maximum of 90 days of coverage before requiring a prior authorization or a new prescription. This is often followed by a limit of one to two refills or until the prescription is updated.

For example, UnitedHealthcare has a coverage limit of 90 days for Vascepa, while Cigna allows two 30-day refills. Your insurance coverage and limit will depend on your specific plan and provider.

What are my options if my insurance limit is reached or if Vascepa is not covered?

If your insurance plan does not cover Vascepa or if you have reached the refill limit, you may want to consider the following options:

- Discuss a prior authorization with your healthcare provider to try and get additional refills covered by your insurance.
- Look into manufacturer assistance programs, such as the Amarin Vascepa Patient Savings Program, which may provide financial assistance for eligible patients.
- Explore generic or biosimilar options, if available.

Can I still get Vascepa if my insurance doesn't cover it?

Yes, you can still get Vascepa if it is not covered by your insurance. However, the cost will be significantly higher out-of-pocket. According to GoodRx, the cash price for Vascepa can range from $200 to $400 per month, depending on the pharmacy and location.

Sources:

[1] Amarin Corporation, Vascepa Patient Savings Program

References:

DrugPatentWatch.com
https://www.drugpatentwatch.com/patent/US-DX2134E/